BioCentury
ARTICLE | Financial News

TG raises $55.2M in debt and equity financings

March 8, 2019 5:32 PM UTC

Cancer and autoimmune company TG Therapeutics raised $25.2 million in a follow-on underwritten by Cantor Fitzgerald through the sale of 4.1 million shares at $5.87. The price is a 13% premium to the company's close of $5.19 on Feb. 27, before it proposed the offering...

BCIQ Company Profiles

TG Therapeutics Inc.